NEW!
Reagent Showcase

Antibodies, Mouse Models



Faculty Info

Disclose an invention and learn more about the Technology Transfer process



Available Technologies

Search technologies that we have available for licensing



UPSTART

Stimulating the creation and growth of new entrepreneurial endeavors



CTT Fellows Program

CTT is seeking highly-talented, scientifically-trained graduate students to assist in managing Penn's invention portfolio.



About CTT

Learn more about the CTT team, read our publications, get directions and contact us



Link To Penn Research

Click here to go to the Penn Research site



Search the UPenn CTT website using Google

Home | Portfolio | Team | Services | Preferred Vendors | Events | Contact Us

 

 

 

 

Portfolio

 

 

Therapeutics Materials
Diagnostics Healthcare IT
Devices  

 

 

 

 

 

 

 

 

 

 


Therapeutics:

Actrx - T-cell adoptive immunotherapies for cancer, infectious diseases, and immune disorders. (Carl June)

Anosos Biotherapeutics - Developing next generation complement modulators, aimed at diseases with a significant inflammatory component. (John Lambris)

Axonia Medical - Proprietary technology platform allowing stretch growth of axon bundles for use as fully functional grafts to address peripheral and CNS neuropathies. (Douglas Smith)

Butterfly Biosciences - Novel RNA therapeutic platform. (Robert Wilson)

Cetazam Therapeutics - Cerebral vascular spasm treatments using Salvia divinorum. (RenYu Liu)

Cloverleaf Therapeutics - tRNA targeted therapeutics for treating cancer and other diseases. (Xiaolu Yang)

DermoBiotech - Human hair follicle stem cell (hHFSC) platform for dermatology-focused regenerative medicine applications. (George Xu)

Directamab - Targeted personalized antibody diagnostic/therapeutic platform. (Nathalie Scholler)

Invidisyn - Developing small-molecule inhibitors of viral nucleic acid synthesis with potent antiviral activity. (Robert Ricciardi)

Key Cytotherapeutics - Developing novel dendritic cell cancer vaccines. (Brian Czerniecki)

Novapeutics - Men1 pathway modulators for diabetes and cancer treatments. (Xianxin Hua)

Quern Therapeutics - Novel reversal agent for Heparin-induced thrombocytopenia (HIT). (Bruce Sachais)

RelGene - cRel inhibitors for multiple sclerosis and other inflammatory diseases. (Youhai Chen)

Vetagenics - Generating canine single chain fragment variable antibody libraries for targeting tumor-associated antigens in canines. (Nicola Mason)

Xymedix - Novel therapeutic antibodies against inflammatory and autoimmune diseases. (Wenchao Song)

Return to Top

 

 

 

Diagnostics:

APlus Radiopharmaceuticals - Molecular imaging agents for early diagnosis of cancers. (Hank Kung)

Cerebromarkers - Developing biomarkers for diagnosis and improved treatment of traumatic brain injury. (Robert Siman)

Cognizance Biomarkers - Biomarkers and potential treatments for epilepsy. (John Pollard)

CytoVas - Novel high-throughput, high-content flow cytometry test for patients at high risk for cardiovascular events. (Emile Mohler)

FibRHO Diagnostics - T1p MR imaging for the non-invasive staging of hepatic fibrosis. (Rebecca Wells)

MicropathID Diagnostics - A pathogen array for the identification of etiological agents associated with disease states. (Erle Robertson)

Return to Top

 

 

 

Devices:

Annulon - Prototyping and testing a catheter-based percutaneous valve replacement technology. (Joseph Gorman and Robert Gorman)

Cerebid Technologies - Color changing blast injury dosimeter(Douglas Smith)

Innofect - Dermal disinfection products for the medical, research and consumer marketplaces. (Paul Axelsen)

Mem Technologies - miRNA quantification platform using nanopores for disease detection and drug discovery. (Marija Drndic)

Oxygense - Developing an optical method and instrument for tissue oxygen measurement and imaging to diagnose and monitor clinically important pathologies, including diabetic retinopathy. (David Wilson)

TIPER Technologies - Precisely controlled and highly efficient cell conversion platform that allows for the creating of custom cell populations (e.g. pluripotent progenitor cells). (James Eberwine)

Virtuscan - Interactive MRI training and simulation software for clinicians and researchers. (Jeremy Magland)

Return to Top

 

 

 

Materials:

Cellulosic Biotherapeutics - Developing novel polysaccharide hydrogels for soft tissue regeneration, including aesthetic medicine applications. (Steven Nicoll)

Fibradigm Therapeutics - Construction of implant materials that mimic the mechanical properties of replaced tissue. (Matthew Fisher)

Graphene Frontiers - Synthesis technologies to produce high quality large scale graphene thin films. (Charles Johnson)

GSL BioLogix - Multi-functional polymers that impart the surface of medical devices with biocompatibility and antibacterial properties. (Russell Composto and David Eckmann)

Myostratum - Developing the use and application of tissue expanding filler materials to promote remodeling of cardiac tissue after infarction. (Robert Gorman and Joseph Gorman)

Nelum Sciences - Surface coatings for a wide range of applications, including superhydrophobicity, superhydrophilicity, highly oleophobicity, anti-fouling and dry adhesion. (Shu Yang)

United Catalyst - Novel imprinted organosilicates used to generate ethanol from cellulose. (Stephen Roth)

Return to Top

 

 


Healthcare IT:

Antray - A software system for tracking usage and experimental data from user-operated equipment. (Wade Rogers)

RightCare Solutions - A post-acute referral decision support system for hospitals and medical centers. (Kathryn Bowles)

Return to Top